Background— Overly aggressive diuresis leading to intravascular volume depletion has been
proposed as a cause for worsening renal function during the treatment of decompensated …

Background: Sodium-glucose cotransporter-2 inhibitors improve heart failure–related
outcomes. The mechanisms underlying these benefits are not well understood, but diuretic …

The vast majority of acute heart failure episodes are characterized by increasing symptoms
and signs of congestion with volume overload. The goal of therapy in those patients is the …

Background : Acute decompensated heart failure (ADHF) can be complicated by electrolyte
abnormalities, but the major focus has been concentrated on the clinical significance of …

Objectives This study compared combination diuretic strategies in acute heart failure (AHF)
complicated by diuretic resistance (DR). Background Combination diuretic regimens to …

Background Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization
for heart failure or death from cardiovascular causes among patients with stable heart …

Heart and kidney are closely related in the clinical syndrome of heart failure (HF). It is now
sufficiently clear that renal dysfunction occurs frequently in all phenotypes of HF, and when …

Appropriate interpretation of changes in markers of kidney function is essential during the
treatment of acute and chronic heart failure. Historically, kidney function was primarily …

Expansion of extracellular fluid volume is central to the pathophysiology of heart failure.
Increased extracellular fluid leads to elevated intracardiac filling pressures, resulting in a …

… Dr Testani reported receiving grants from the National Institutes of Health during the … In
addition, Dr Testani had a patent for treatment of diuretic resistance with royalties paid from Yale …